Labcorp launches new test to identify and confirm neurodegenerative disease

Burlington, n.c.--(business wire)--labcorp (nyse: lh), a leading global life sciences company, today announced the launch of the first widely accessible test that provides direct evidence of neurodegeneration and neuronal injury. the new neurofilament light chain (nfl) blood test will allow doctors to identify and verify signs of neurodegenerative disease, enabling physicians to provide a more effective and efficient path to diagnosis and treatment for patients. elevated nfl levels signal neuro
LH Ratings Summary
LH Quant Ranking